Bone marrow transplantation in patients with thalassemia
Stella Santarone, Paola Olioso, Erminia Di Bartolomeo, Pasqua Bavaro, Gabriele Papalinetti, Paola Di Carlo, Paolo Di Bartolomeo
Abstract
Stella Santarone, Paola Olioso, Erminia Di Bartolomeo, Pasqua Bavaro, Gabriele Papalinetti, Paola Di Carlo, Paolo Di Bartolomeo
Abstract
In this study we report the long-term results of bone marrow transplantation (BMT) in 113 patients (M 56, F 57) with thalassemia major (TM) who were given 117 transplants from HLA identical sibling donor between May 1983 and September 2005. The median age was 9.09 years (0.11-28.11). The median number of transfusions given before BMT was 136 (2-900). The pretransplant liver biopsy performed in 78 patients showed: chronic persistent hepatitis in 35, mild chronic active hepatitis (CAH) in 10, moderate CAH in 23, severe CAH in 10.
OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
In this study we report the long-term results of bone marrow transplantation (BMT) in 113 patients (M 56, F 57) with thalassemia major (TM) who were given 117 transplants from HLA identical sibling donor between May 1983 and September 2005. The median age was 9.09 years (0.11-28.11). The median number of transfusions given before BMT was 136 (2-900). The pretransplant liver biopsy performed in 78 patients showed: chronic persistent hepatitis in 35, mild chronic active hepatitis (CAH) in 10, moderate CAH in 23, severe CAH in 10.
Key concepts: Medicine, Surgery, Cyclophosphamide, Gastroenterology, Thalassemia, Methotrexate, Bone marrow, Internal medicine